Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.
about
Umbilical cord blood: an evolving stem cell source for sickle cell disease transplantsNew frontiers in pediatric Allo-SCT.Hematopoietic stem cell transplantation for sickle cell disease: state of the science.Human leukocyte antigen distribution and genomic ancestry in Brazilian patients with sickle cell disease.The past, present and future management of sickle cell retinopathy within an African context
P2860
Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Allogeneic cellular and autolo ...... disease: 'whom, when and how'.
@en
Allogeneic cellular and autolo ...... disease: 'whom, when and how'.
@nl
type
label
Allogeneic cellular and autolo ...... disease: 'whom, when and how'.
@en
Allogeneic cellular and autolo ...... disease: 'whom, when and how'.
@nl
prefLabel
Allogeneic cellular and autolo ...... disease: 'whom, when and how'.
@en
Allogeneic cellular and autolo ...... disease: 'whom, when and how'.
@nl
P2093
P2860
P356
P1476
Allogeneic cellular and autolo ...... disease: 'whom, when and how'
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2011.245
P407
P50
P577
2011-12-19T00:00:00Z